4.8 Review

The knowns and unknowns of latent Mycobacterium tuberculosis infection

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 131, 期 3, 页码 -

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI136222

关键词

-

资金

  1. NIH/National Institute of Allergy and Infectious Diseases [AI146329, AI127173, AI117927, AI125642, AI124348, AI147319, 75N93019C00071]
  2. Leibniz Research Alliance INFECTIONS21, Leibniz Science Campus Evolung
  3. German Science Foundation [IRTG 1911, Scha 514 5-1]
  4. Ministry of Education and Research (German Center for Infection Research, TB-Sequel)

向作者/读者索取更多资源

Humans have been suffering from Mycobacterium tuberculosis (Mtb) infection for thousands of years. While most infected individuals remain asymptomatic, some can clear the infection. Successful control of Mtb infection requires the involvement of various immune mechanisms due to Mtb's ability to evade the immune system.
Humans have been infected with Mycobacterium tuberculosis (Mtb) for thousands of years. While tuberculosis (TB), one of the deadliest infectious diseases, is caused by uncontrolled Mtb infection, over 90% of presumed infected individuals remain asymptomatic and contain Mtb in a latent TB infection (LTBI) without ever developing disease, and some may clear the infection. A small number of heavily Mtb-exposed individuals appear to resist developing traditional LTBI. Because Mtb has mechanisms for intracellular survival and immune evasion, successful control involves all of the arms of the immune system. Here, we focus on immune responses to Mtb in humans and nonhuman primates and discuss new concepts and outline major knowledge gaps in our understanding of LTBI, ranging from the earliest events of exposure and infection to success or failure of Mtb control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据